Vimarsana
Biggest News Aggregation in the World

Api Holdings Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Api Holdings Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Api Holdings Ltd Today - Breaking & Trending Today

Top 10 at 10: These ASX seafood, copper and rare earths stocks are getting snapped up in early trade - Vimarsana News

Top 10 at 10: These ASX seafood, copper and rare earths stocks are getting snapped up in early trade

Top 10 at 10: These ASX seafood, copper and rare earths stocks are getting snapped up in early trade

PharmEasy parent withdraws IPO plans, weighs rights issue to raise funds - Vimarsana News

PharmEasy parent withdraws IPO plans, weighs rights issue to raise funds

The price is expected to be ₹100 per share and is set to open around the first week of September, the document showed

Weekly Small Cap and IPO Wrap: The pandemic party is done, hello the post-pandemic crisis - Vimarsana News

Weekly Small Cap and IPO Wrap: The pandemic party is done, hello the post-pandemic crisis

Weekly Small Cap and IPO Wrap: The pandemic party is done, hello the post-pandemic crisis

Rise and Shine: What you need to know before the ASX opens - Vimarsana News

Rise and Shine: What you need to know before the ASX opens

Rise and Shine: What you need to know before the ASX opens

Healthcare Unicorn Pharmeasy Acquires Majority Stake In Thyrocare Technologies: Report - Vimarsana News

Healthcare Unicorn Pharmeasy Acquires Majority Stake In Thyrocare Technologies: Report

Healthcare Unicorn Pharmeasy Acquires Majority Stake In Thyrocare Technologies: Report PharmEasy (Source: Entrackr) API Holdings Ltd (API), the parent company of digital healthcare brand Pharmeasy, is set to acquire automated accredited diagnostic laboratory Thyrocare Technologies, making the first such deal of a listed entity by an Indian unicorn. API Holdings has signed definitive documents to acquire 66.1 per cent stake in Thyrocare Technologies Ltd (Thyrocare) from Dr A. Velumani and affiliates at a price of Rs 1,300 per share aggregating to Rs 4,546 crore. The transaction is subject to r...